Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 3/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.46 |
| ▸ | CTSS | P25774 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.44 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.42 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7464405 | 1.00 | SLC7A5 (0.57) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL630703 | 1.00 | SLC7A5 (0.57) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL27704336 | 0.98 | SLC7A5 (0.56) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL4422991 | 0.98 | SLC7A5 (0.56) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| Hydrochloric Acid SCHEMBL7687022 | 0.98 | SLC7A5 (0.56) | SLC7A5TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL7395431 | 0.88 | ACACB (0.44) | SLC7A5ESR1ESR2CTSSCTSK | |
| SCHEMBL6666822 | 0.87 | SLC7A5 (0.45) | SLC7A5 | |
| SCHEMBL3203564 | 0.87 | SLC7A5 (0.45) | SLC7A5 | |
| SCHEMBL17978113 | 0.87 | SLC7A5 (0.45) | SLC7A5 | |
| SCHEMBL17978114 | 0.87 | SLC7A5 (0.45) | SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 664 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079826-A | HDAC inhibitor based on tyrosine skeleton, and synthesis method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-12582742-B2 | Packaging solutions | BAUSCH + LOMB IRELAND LIMITED (IE) | 2026-03-24 | — | — | US | claimed |
| US-20260027227-A1 | NOVEL THIOL REDUCTANT, METHOD AND USE THEREOF | SUZHOU BIOREINNO BIOTECHNOLOGY LTD COMPANY (CN) | 2026-01-29 | — | — | US | claimed |
| US-20250326775-A1 | A NOVEL THIOL REDUCTANT, PREPARATION METHOD AND USE THEREOF | SUZHOU BIOREINNO BIOTECHNOLOGY LTD COMPANY (CN) | 2025-10-23 | — | — | US | claimed |
| EP-4577552-A1 | A NOVEL THIOL REDUCTANT, METHOD AND USE THEREOF | SUZHOU BIOREINNO BIOTECHNOLOGY LIMITED COMPANY (CN) | 2025-07-02 | — | — | EP | claimed |
| EP-4536670-A1 | A NOVEL THIOL REDUCTANT, PREPARATION METHOD AND USE THEREOF | SUZHOU BIOREINNO BIOTECHNOLOGY LIMITED COMPANY (CN) | 2025-04-16 | — | — | EP | claimed |
| CN-119470406-A | Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof | 山东新华莎罗雅生物技术有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119365471-A | Novel thiol reducing agents, methods and uses thereof | 苏州佰睿壹生物技术有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119241385-A | Beta-acyloxy enamide derivative and preparation method and application thereof | 江西师范大学 | 2025-01-03 | — | — | CN | claimed |
| WO-2024041541-A1 | A NOVEL THIOL REDUCTANT, METHOD AND USE THEREOF | SUZHOU BIOREINNO BIOTECHNOLOGY LIMITED COMPANY (CN) | 2024-02-29 | — | — | WO | claimed |
| CN-102320950-A | Method for synthesizing acetic acid through carbonylation | SHANGHAI HUAYI GROUP CO | 2012-01-18 | — | — | CN | claimed |
| CN-101658800-B | Catalyst system for use in preparation of acetic acid and acetic anhydride or synchronous preparation of acetic acid and acetic anhydride and preparation method thereof | SHANGHAI COKING & CHEM CORP | 2011-11-02 | — | — | CN | claimed |
| CN-101927201-A | Method for removing impurities from solution of acetic acid and/or acetic anhydride hydroformylation catalyst | SHANGHAI COKING & CHEM CORP | 2010-12-29 | — | — | CN | claimed |
| CN-101658800-A | Catalyst system for use in preparation of acetic acid and acetic anhydride or synchronous preparation of acetic acid and acetic anhydride and preparation method thereof | SHANGHAI COKING & CHEMICAL COR | 2010-03-03 | — | — | CN | claimed |
| CN-101659607-A | Method for preparing acetic acid and acetic anhydride respectively or synchronously | SHANGHAI COKING & CHEMICAL COR | 2010-03-03 | — | — | CN | claimed |
| EP-1051195-A4 | IDENTIFICATION OF AGENTS THAT PROTECT AGAINST INFLAMMATORY INJURY TO NEURONS | BAYLOR COLLEGE MEDICINE (US) | 2004-06-09 | — | — | EP | claimed |
| EP-1051195-A1 | IDENTIFICATION OF AGENTS THAT PROTECT AGAINST INFLAMMATORY INJURY TO NEURONS | BAYLOR COLLEGE OF MEDICINE (US) | 2000-11-15 | — | — | EP | claimed |
| CN-1265672-A | Sulphonylated dipeptide Compounds capable of inhibiting leukocyte adhesion mediated by VLA-4 | ELAND PHARMACEUTICALS CO (US) | 2000-09-06 | — | — | CN | claimed |
| US-6043283-A | ADMINISTERING TYRAMINE COMPOUND TO PATIENT TO INHIBIT INJURY, DESTRUCTION OR DEATH OF NEURONS | BAYLOR COLLEGE OF MEDICINE (US) | 2000-03-28 | — | — | US | claimed |
| WO-1998011923-A1 | IDENTIFICATION OF AGENTS THAT PROTECT AGAINST INFLAMMATORY INJURY TO NEURONS | BAYLOR COLLEGE OF MEDICINE (US) | 1998-03-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027227-A1 | NOVEL THIOL REDUCTANT, METHOD AND USE THEREOF | CBR1, SCLY, SSB | SLC7A5 251/4885TAAR1 1769/4885SLC6A2 3125/4885 |
| US-20250326775-A1 | A NOVEL THIOL REDUCTANT, PREPARATION METHOD AND USE THEREOF | TMT1A, TST, PRDX3 | SLC7A5 2322/4885TAAR1 3472/4885SLC6A2 3672/4885 |
| US-12582742-B2 | Packaging solutions | CD44, DSG1, HPSE | SLC7A5 410/4885TAAR1 2737/4885SLC6A2 1713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.